Introducing Australia’s first Quantitative Digital Pathology – Immunohistochemistry Section
MetaGene and Applied Spectral Imaging (ASI) are proud to support the Menzies Health Institute Queensland in the creation of the country’s first Quantitative Digital Pathology – Immunohistochemistry Section (QDP-IHC).
MetaGene Announces TGA Approval For Groundbreaking New Digital Pathology System
In an Australian first, the Federal Government has granted TGA approval for a diagnostic digital pathology system set to radically improve the outlook for cancer patients through rapid and accurate diagnosis. MetaGene has received TGA class III Medical Device certification for GenASIs – a groundbreaking diagnostic platform offering quantitative, accurate and validated analysis of patient samples in a clinical setting.